Jochen Hanns-Martin Lorch

  • Source: Scopus
20022022

Research activity per year

If you made any changes in Pure these will be visible here soon.

Network

Robert I. Haddad

  • Dana-Farber/Brigham and Women's Cancer Center
  • Harvard University
  • Dana-Farber Cancer Institute
  • Case Western Reserve University
  • Brigham and Women's Cancer Center
  • Dana-Farber
  • Johns Hopkins University
  • Northwestern University
  • Da-na-Farber/Brigham and Women’s Cancer Center
  • 17Dana-Farber/Brigham and Women's Cancer Center
  • Department of Medical Oncology

External person

Glenn J. Hanna

  • Department of Medical Oncology
  • Dana-Farber Cancer Institute
  • Harvard University

External person

Roy B. Tishler

  • Harvard University
  • Dana-Farber Cancer Institute

External person

Jonathan D. Schoenfeld

  • Harvard University
  • Department of Radiation Oncology
  • Dana-Farber Cancer Institute

External person

Nicole G. Chau

  • Department of Medical Oncology
  • Dana-Farber Cancer Institute
  • BC Cancer
  • Harvard University
  • British Columbia Cancer

External person

Danielle N. Margalit

  • Harvard University
  • Dana-Farber Cancer Institute

External person

Marshall R. Posner

  • Harvard University
  • Icahn School of Medicine at Mount Sinai
  • Dana-Farber Cancer Institute

External person

Justine A. Barletta

  • Harvard University
  • Departments of Pathology

External person

Laura A. Goguen

  • Harvard University
  • Dana-Farber Cancer Institute

External person

Guilherme Rabinowits

  • Baptist Hospital Miami
  • Dana-Farber Cancer Institute
  • Harvard University
  • Miami Cancer Institute
  • Hematology/Oncology
  • Hematology/Oncology

External person

Donald J. Annino

  • Harvard University
  • Dana-Farber Cancer Institute

External person

Matthew Nehs

  • Harvard University

External person

Erik K. Alexander

  • Harvard University

External person

Ellen Marqusee

  • Harvard University

External person

Ravindra Uppaluri

  • Washington University St. Louis
  • Dana-Farber Cancer Institute
  • Harvard University

External person

Lori J. Wirth

  • Harvard University
  • Cancer Center
  • Department of Medicine
  • Dana-Farber Cancer Institute

External person

Kristine S. Wong

  • Harvard University

External person

Nancy Cho

  • Harvard University

External person

Vickie Y. Jo

  • Harvard University
  • Department of Pathology

External person

Gerard M. Doherty

  • Washington University St. Louis
  • University of Michigan, Ann Arbor
  • Boston University
  • Surgery/Surgical Oncology
  • Harvard University
  • Department of Surgery
  • Department of Surgery
  • School of Medicine

External person

Alec Kacew

  • Dana-Farber Cancer Institute

External person

Peter S. Hammerman

  • Harvard University
  • Dana-Farber Cancer Institute
  • Broad Institute
  • Massachusetts Institute of Technology
  • Department of Medical Oncology
  • Department of Medical Oncology
  • Department of Medicine

External person

David Sher

  • Boston University
  • Department of Radiation Oncology
  • University of Texas Southwestern Medical Center
  • Harvard University
  • Rush University
  • UT Southwestern Simmons Comprehensive Cancer Center

External person

O. Goloubeva

  • University of Maryland, Baltimore
  • Dana-Farber Cancer Institute
  • Department of Epidemiology and Public Health
  • School of Medicine

External person

Sewanti A. Limaye

  • Dana-Farber Cancer Institute
  • Harvard University

External person

N. J. Sarlis

  • Fox Chase Cancer Center
  • Sanofi Aventis
  • Department of Medical Affairs-Oncology
  • Sanofi-Aventis

External person

Patrick Lizotte

  • Dana-Farber Cancer Institute

External person

Bhupendra Rawal

  • Dana-Farber Cancer Institute
  • Harvard University
  • PRA Health Sciences

External person

Ethan J. Harris

  • Dana-Farber Cancer Institute
  • University of Illinois at Chicago
  • St. Jude Children Research Hospital

External person

F. D. Moore

  • Harvard University

External person

Paul Catalano

  • University of Pennsylvania
  • Vanderbilt University
  • Northwestern University
  • Dana-Farber Cancer Institute
  • Harvard University
  • Statistical Center
  • Eastern Cooperative Oncology Group
  • ECOG Eastern Cooperative Oncology Group Statistical Center
  • Wayne State University
  • Eastern Cooperative Oncology Group
  • Department of Biostatistics and Computational Biology
  • Department of Biostatistics and Computational Biology
  • Department of Biostatistical Science
  • Department of Biostatistics
  • Department of Biostatistics
  • Department of Bisotatistics and Computational Biology
  • Mayo Clinic Rochester, MN
  • ECOG-ACRIN Biostatistics Center
  • Eastern Cooperative Oncology Group
  • Queen's University Belfast

External person

Jeffrey F. Krane

  • University of Geneva
  • Harvard University
  • Department of Pathology
  • Department of Pathology
  • Vascular Research Division
  • University of California at Los Angeles

External person

Eleni M. Rettig

  • Dana-Farber Cancer Institute
  • Harvard University
  • Johns Hopkins University

External person

Kevin J. Cullen

  • University of Maryland, Baltimore
  • Vincent T. Lombardi Cancer Center
  • Vincent T. Lombardi Cancer Center

External person

Charles M. Norris

  • Harvard University
  • Dana-Farber Cancer Institute

External person

Pasi A. Janne

  • University of Pennsylvania
  • Infect. Diseases Society of America
  • Dana-Farber Cancer Institute
  • Harvard University
  • Belfer Institute for Applied Cancer Science
  • American Society of Clinical Oncology

External person

Megan Cavanaugh

  • Dana-Farber Cancer Institute

External person

Vishwajith Sridharan

  • Harvard University
  • Harvard-MIT Division of Health Sciences and Technology
  • Dana-Farber Cancer Institute

External person

Daniel T. Ruan

  • Harvard University
  • Department of Surgery
  • Departments of Surgery

External person

Tom Thomas

  • Dana-Farber Cancer Institute
  • Harvard University

External person

Anne O'Neill

  • Dana-Farber Cancer Institute
  • Department of Biostatistics and Computational Biology

External person

Lisa M. Schumaker

  • University of Maryland, Baltimore
  • Vincent T. Lombardi Cancer Center

External person

Elena Ivanova

  • Dana-Farber Cancer Institute

External person

Michaela Bowden

  • Dana-Farber Cancer Institute
  • Harvard University
  • Center for Molecular Oncologic Pathology
  • Department of Medical Oncology
  • Department of Pathology
  • Department of Medical Oncology

External person

Vijaya Thotakura

  • Harvard University
  • Dana-Farber Cancer Institute

External person

Eliezer M. Van Allen

  • Broad Institute
  • Dana-Farber Cancer Institute
  • Massachusetts Institute of Technology
  • Cancer Genome Atlas Program Office
  • National Institutes of Health
  • Department of Medical Oncology
  • Cancer Program
  • Harvard University

External person

Laura E. MacConaill

  • Dana-Farber Cancer Institute
  • Department of Medical Oncology
  • Harvard University
  • Dana-Farber/Brigham and Women's Cancer Center

External person

David A. Barbie

  • Broad Institute
  • Massachusetts Institute of Technology
  • Dana-Farber Cancer Institute
  • Department of Medical Oncology
  • Harvard University

External person

Cloud P. Paweletz

  • Dana-Farber Cancer Institute

External person

Hongye Liu

  • Dana-Farber Cancer Institute
  • Harvard University

External person

Manisha Thakuria

  • Harvard University
  • Dana-Farber Cancer Institute
  • Cutaneous Oncology

External person

Tyler Haddad

  • Harvard University
  • Ohio State University
  • Dana-Farber Cancer Institute

External person

Ji Eun Bae

  • Dana-Farber Cancer Institute

External person

Kwok Kin Wong

  • Dana-Farber Cancer Institute
  • Harvard University
  • New York University

External person

Y. Y. Li

  • Dana-Farber Cancer Institute
  • Harvard University
  • Broad Institute

External person

Yu Hui Chen

  • Department of Biostatistics and Computational Biology
  • Dana-Farber Cancer Institute
  • American College of Radiology Imaging Network Cancer Research Group
  • Eastern Cooperative Oncology Group
  • Harvard University

External person

Nicole LeBoeuf

  • Dana-Farber Cancer Institute
  • Harvard University
  • Cutaneous Oncology

External person

Gypsyamber D'Souza

  • University of Illinois at Chicago
  • Johns Hopkins University
  • National Institutes of Health
  • Bloomberg School of Public Health
  • Department of Epidemiology
  • Department of Epidemiology
  • Department of Epidemiology
  • School of Public Health
  • Department of Medicine and Department of Epidemiology
  • Kaiser Permanente

External person

Tracy A. Balboni

  • Dana-Farber Cancer Institute
  • Harvard University
  • Departments of Radiation Oncology

External person

Julian Huang

  • Dana-Farber Cancer Institute
  • Yale University

External person

Jason I. Kass

  • Harvard University
  • Dana-Farber Cancer Institute
  • Reliant Medical Group

External person

Carole Fakhry

  • Department of Neurology
  • Johns Hopkins University

External person

Jeffery S. Russell

  • Immunocore
  • University of South Florida

External person

Trevor E. Angell

  • University of Southern California
  • Harvard University

External person

William G. Richards

  • Harvard University
  • Department of Thoracic Surgery

External person

Roger D. Kamm

  • University of Toronto
  • Boston University
  • Massachusetts Institute of Technology
  • Eye Pathology Lab
  • Mechanical Engineering Department
  • Mechanical Engineering
  • Department of Biological Engineering
  • Department of Mechanical Engineering
  • School of Medicine
  • Department of Ophthalmology

External person

Jong C. Park

  • Harvard University

External person

Scott L. Carter

  • Dana-Farber Cancer Institute
  • Harvard University
  • Broad Institute
  • Massachusetts Institute of Technology
  • National Institutes of Health

External person

Shailender Bhatia

  • Seattle Cancer Care Alliance
  • Seattle Cancer Care Alliance
  • University of Washington

External person

Gordon J. Freeman

  • Bristol-Myers Squibb
  • Dana-Farber Cancer Institute
  • Harvard University
  • Department of Medical Oncology
  • Department of Medical Oncology
  • Lab. for Neurodeg. and Aging Res.
  • Department of Medical Oncology

External person

Raphael Bueno

  • Harvard University
  • Division of Thoracic Surgery
  • Div. Thorac. Surg. Pulmon./C.
  • Thoracic Surgery
  • Division of Thoracic Surgery
  • Department of Thoracic Surgery

External person

Brett Miles

  • Icahn School of Medicine at Mount Sinai
  • Northwell Health
  • Northwell Health System

External person

Shuai Li

  • Dana-Farber Cancer Institute

External person

Chensheng W. Zhou

  • Dana-Farber Cancer Institute

External person

Michelle Flynn

  • Dana-Farber Cancer Institute

External person

Hua Zhang

  • Dana-Farber Cancer Institute

External person

Sangeetha Palakurthi

  • AstraZeneca
  • Clinical Research
  • Dana-Farber Cancer Institute

External person

Mark Bittinger

  • Dana-Farber Cancer Institute

External person

Karl Lewis

  • University of Colorado Denver
  • University of Colorado Boulder
  • University of Colorado Cancer Center
  • University of Colorado Cancer Center
  • Department of Medicine
  • Department of Medicine
  • University of Colorado Cancer Center
  • University of Colorado Anschutz Medical Campus
  • University of Michigan, Ann Arbor

External person

Elaine Burke

  • Dana-Farber Cancer Institute
  • Harvard University

External person

Harry Quon

  • University of Pennsylvania
  • Johns Hopkins University

External person

Scott J. Rodig

  • Harvard University
  • Department of Pathology
  • Washington University St. Louis
  • Dana-Farber Cancer Institute

External person

Shana Criscitiello

  • Harvard University

External person

Fred Wang

  • Harvard University
  • Division of General Medicine
  • Elmhurst Bldg.
  • Dept. of Pathology
  • Roger Williams Hospital

External person

Paul Nghiem

  • University of Washington
  • Harvard University
  • Fred Hutchinson Cancer Research Center
  • Fox Chase Cancer Center
  • Seattle Cancer Care Alliance
  • Department of Pathology
  • Department of Dermatology
  • Department of Medicine (Dermatology)
  • Clinical Research Division
  • Seattle Cancer Care Alliance

External person

Rosh K V Sethi

  • Harvard University

External person

Chi Iou Lin

  • Harvard University

External person

Jason Glass

  • Dana-Farber Cancer Institute

External person

Kent Shih

  • Sarah Cannon Research Institute
  • Sarah Cannon Research Institute

External person

Thomas C. Lee

  • Harvard University

External person

Jiehui Deng

  • Dana-Farber Cancer Institute
  • New York University

External person

Mark H. Fogg

  • Harvard University
  • Division of General Medicine
  • Abzena

External person

Omid Hamid

  • Angeles Clinic and Research Institute
  • Wayne State University
  • Eli Lilly
  • Experimental Therapeutics/Immunotherapy
  • Department of Oncology
  • Melanoma Therapeutics
  • Cedars-Sinai Medical Center
  • Medical Oncology

External person

Wei Huang

  • Dana-Farber Cancer Institute

External person

P. Terheyden

  • Kiel University
  • Universitätsklinikum Schleswig-Holstein Campus Lübeck
  • University of Lübeck

External person

Michele Milella

  • IRCCS Istituti fisioterapici ospitalieri - Istituto Regina Elena
  • University and Hospital Trust of Verona
  • University and Hospital Trust of Verona

External person

Neil D. Gross

  • University of Texas MD Anderson Cancer Center

External person

Phillip Groden

  • Icahn School of Medicine at Mount Sinai
  • Dana-Farber Cancer Institute

External person

Victoria Vergara

  • Dana-Farber Cancer Institute
  • Harvard University

External person

M. E. Cabanillas

  • University of Texas MD Anderson Cancer Center

External person

Tiffany Y. Chen

  • Harvard University

External person

Abha Aggarwal

  • Harvard University

External person

Eric S. Wang

  • Dana-Farber Cancer Institute
  • Harvard University

External person

F. Stephen Hodi

  • Dana-Farber/Brigham and Women's Cancer Center
  • Dana-Farber Cancer Institute
  • University of Pennsylvania
  • Harvard University
  • Dana-Farber
  • Department of Medical Oncology
  • Department of Medical Oncology
  • Melanoma Disease Center
  • Bristol-Myers Squibb
  • Charité – Universitätsmedizin Berlin

External person

Jeremy D. Richmon

  • Johns Hopkins University
  • Harvard University
  • Department of Otolaryngology-Head and Neck Surgery
  • Head and Neck Cancer Research Division
  • Department of Otolaryngology
  • Department of Otolaryngology–Head and Neck Surgery
  • Division of Thyroid and Parathyroid Endocrine Surgery

External person

Sara Isabel Pai

  • Johns Hopkins University
  • Department of Otolaryngology-Head and Neck Surgery
  • Department of Oncology
  • Department of Oncology

External person

Ashley Merlino

  • Dana-Farber Cancer Institute

External person

Ming Tan

  • University of Maryland, Baltimore

External person

Amanda J. Rode

  • Dana-Farber Cancer Institute

External person

Joseph H. Killoran

  • Harvard University

External person

Priyanka Shivdasani

  • Harvard University
  • Department of Pathology and

External person

Antonio Calles

  • Centro Integral Oncologico Clara Campal
  • START Madrid
  • Complutense University
  • Dana-Farber Cancer Institute

External person

Matthew Sanborn

  • Dana-Farber Cancer Institute

External person

Geoffrey I. Shapiro

  • Dana-Farber Cancer Institute
  • Harvard University
  • Department of Medicine
  • Department of Medical Oncology
  • Early Drug Development Center

External person

Sandra P. D'Angelo

  • Memorial Sloan-Kettering Cancer Center
  • Cornell University
  • Gynecologic Medical Oncology Service

External person

Sareh Parangi

  • Harvard University
  • Department of Surgery
  • Department of Surgery
  • Department of Surgery
  • Department of Neurointerventional Surgery

External person

Wieland Voigt

  • Martin Luther University Halle-Wittenberg
  • Dana-Farber Cancer Institute

External person

Genevieve M. Boland

  • National Institutes of Health
  • Cancer Genome Atlas Program Office
  • Harvard University

External person

Jerome Ritz

  • Dana-Farber Cancer Institute
  • Department of Medical Oncology
  • Harvard University

External person

Jo Ann Fugazzotto

  • Dana-Farber Cancer Institute
  • Harvard University

External person

Jennifer M. Cutler

  • Dana-Farber Cancer Institute

External person

Edward E. Whang

  • Harvard University

External person

Russell W. Jenkins

  • Dana-Farber Cancer Institute
  • Harvard University

External person

Viswanath Gunda

  • Harvard University

External person

Robert E. Jones

  • Dana-Farber Cancer Institute

External person

Umair Mahmood

  • Dana-Farber Cancer Institute

External person

Ming Tan

  • University of Maryland, Baltimore

External person

Howard L. Kaufman

  • Rutgers - The State University of New Jersey, New Brunswick
  • Rush University
  • Columbia University
  • Department of General Surgery
  • Morgan Stanley Children's Hospital of New York-Presbyterian
  • Department of Surgery
  • Replimune
  • Harvard University

External person

Celeste Lebbé

  • Université Paris 7
  • Service de Dermatologie
  • INSERM UMR773
  • Institut national de la santé et de la recherche médicale
  • Université Paris Cité

External person

Anupam Desai

  • Harvard University

External person

Neal I. Lindeman

  • Harvard University
  • Department of Pathology
  • Department of Pathology

External person

Mariano Severgnini

  • Dana-Farber Cancer Institute

External person

Max Quinn

  • Dana-Farber Cancer Institute

External person

Christine G. Gourin

  • Johns Hopkins University

External person

Krzysztof J. Misiukiewicz

  • Icahn School of Medicine at Mount Sinai

External person

Peter E. Andersen

  • Oregon Health and Science University

External person

Patrick A. Ott

  • New York University
  • Dana-Farber Cancer Institute
  • Harvard University
  • Dana-Farber/Brigham and Women's Cancer Center
  • Department of Medicine
  • Melanoma Disease Center
  • Da-na-Farber/Brigham and Women’s Cancer Center

External person

Alicia Wentz

  • Johns Hopkins University

External person

Levi A. Garraway

  • Dana-Farber Cancer Institute
  • Harvard University
  • Massachusetts Institute of Technology
  • National Institutes of Health
  • Broad Institute
  • Departments of Medicine and Pathology
  • Departments of Medicine, Pathology, and Radiation Oncology
  • Department of Biostatistics and Computational Biology
  • Cancer Genome Atlas Program Office
  • Department of Medical Oncology
  • Department of Medical Oncology
  • Department of Medical Oncology
  • Melanoma Program in Medical Oncology
  • Center for Cancer Genome Discovery
  • Department of Medical Oncology
  • Department of Medical Oncology and the Center for Cancer Genome Discovery
  • Department of Medical Oncology
  • Department of Medicine
  • Department of Medicine
  • Department of Medicine

External person

Amaro Taylor-Weiner

  • Broad Institute
  • Massachusetts Institute of Technology

External person

Isaac Brownell

  • National Institutes of Health
  • New England Dermatology and Laser Center
  • Dermatology Branch
  • KU Leuven

External person

K. S. Anderson

  • Dana-Farber Cancer Institute
  • Arizona State University

External person

Mona Arbab

  • Harvard University
  • Indiana University-Purdue University Indianapolis

External person

Stefan Kraft

  • Harvard University

External person

Amir R. Aref

  • Dana-Farber Cancer Institute

External person

Nathanael S. Gray

  • Novartis
  • Dana-Farber Cancer Institute
  • Genom. Inst. Novartis Res. Found.
  • Harvard University
  • Department of Cancer Biology
  • Department of Biological Chemistry and Molecular Pharmacology
  • Dept. Biol. Chem. Molec. Pharmacol.

External person

Israel Cañadas

  • Dana-Farber Cancer Institute

External person

J. Wong

  • Dana-Farber Cancer Institute

External person

Maria Anguiano

  • University of Navarra

External person

Evisa Gjini

  • Dana-Farber Cancer Institute
  • Harvard University

External person

Michelle Afkhami

  • City of Hope National Med Center

External person

Jessica A. Marshall

  • Harvard University

External person

Z. Euler

  • Harvard University

External person

Jun Zhou

  • Dana-Farber Cancer Institute

External person

Alarice C. Lowe

  • Stanford University

External person

Mary C. Frates

  • Harvard University
  • Center for Neurological Imaging

External person

Jong Wook Kim

  • Massachusetts Institute of Technology
  • Dana-Farber Cancer Institute
  • Department of Medical Oncology

External person

Annan Yang

  • Dana-Farber Cancer Institute

External person

Thanh U. Barbie

  • Harvard University

External person

Roger Davis

  • Harvard University
  • Department of Medicine
  • Div. of Gen. Med. and Primary Care
  • Division of General Internal Medicine and Primary Care
  • Cardiovascular Division
  • Department of Medicine
  • Lab. for Neurodeg. and Aging Res.
  • Department of Biostatistics
  • Research Triangle Park
  • Division of Infectious Diseases
  • University of North Carolina at Chapel Hill
  • Indiana University-Purdue University Indianapolis
  • Department of Medicine
  • University of Southern California
  • Department of Medicine
  • Department of Medicine
  • Cornell University
  • Division of General Medicine and Primary Care
  • National Institutes of Health
  • Stony Brook University
  • Washington University St. Louis
  • University of Cincinnati
  • Clinical Center and Division of AIDS
  • AIDS Clinical Trials Group Statistic and Data Analysis Center
  • RTI International

External person

S. B. Woo

  • Dana-Farber Cancer Institute
  • Harvard University

External person

Mikel Lipschitz

  • Dana-Farber Cancer Institute
  • Harvard University

External person

Carol B. Benson

  • Harvard University
  • Center for Neurological Imaging

External person

T. K. Pandian

  • Harvard University

External person

Rameen Beroukhim

  • Broad Institute
  • Harvard University
  • Massachusetts Institute of Technology
  • Dana-Farber Cancer Institute
  • National Institutes of Health
  • Department of Medicine
  • Department of Medical Oncology
  • Cancer Genome Atlas Program Office
  • Lab. for Neurodeg. and Aging Res.
  • Cancer Program
  • Department of Medicine
  • Departments of Cancer Biology and Medical Oncology
  • Departments of Medicine and Pathology
  • Departments of Medicine, Pathology, and Radiation Oncology
  • Department of Biostatistics and Computational Biology
  • Center for Neuro-Oncology
  • Department of Medical Oncology
  • Department of Neurosurgery
  • Department of Cancer Biology
  • Department of Medical Oncology
  • Department of Medicine
  • Department of Medical Oncology
  • Cancer Biology
  • Center for Cancer Genome Discovery
  • Department of Medical Oncology and the Center for Cancer Genome Discovery
  • Department of Medical Oncology
  • Department of Medicine
  • Center for Neuro-Oncology
  • Dana-Farber/Brigham and Women's Cancer Center
  • Departments of Medical and Pediatric Oncology
  • Department of Genetics
  • University of North Carolina at Chapel Hill
  • Department of Medicine
  • Department of Cancer Biology
  • Department of Medicine
  • Program in Biophysics
  • Department of Medicine
  • Bioinformatics and Integrative Genomics

External person

D. Heirich

  • Loxo Oncology

External person

Mark A. Vivian

  • University of Manitoba

External person

Keith Flaherty

  • University of Pennsylvania
  • Harvard University
  • National Institutes of Health
  • Department of Medicine and Pathology
  • Cancer Genome Atlas Program Office
  • Department of Medicine
  • Department of Medicine
  • Division of Hematology and Oncology
  • Division of Hematology and Oncology
  • Developmental Therapeutics
  • Termeer Center for Targeted Therapy
  • Developmental Therapeutics
  • Department of Medicine
  • Boston University
  • Massachusetts General Hospital Cancer Center
  • Termeer Center for Targeted Therapy

External person

Emily M. Thrash

  • Dana-Farber Cancer Institute

External person

Paul M. Busse

  • Harvard University
  • Case Western Reserve University
  • Department of Radiation Oncology
  • Johns Hopkins University
  • Northwestern University

External person

Vera A. Paulson

  • University of Washington
  • Harvard University

External person

Mathew I. Kim

  • Harvard University

External person

B. Solomon

  • Peter Maccallum Cancer Centre
  • University of Melbourne
  • Avera Health

External person

Amy X. Zhong

  • Massachusetts Institute of Technology

External person

Anna W. LaVigne

  • Johns Hopkins University

External person

Diana Miao

  • Massachusetts Institute of Technology
  • Dana-Farber Cancer Institute

External person

Kemal Tuncali

  • Harvard University
  • Department of Radiology
  • Department of Radiology

External person

Mai P. Hoang

  • Harvard University

External person

Iñigo Landa

  • Harvard University

External person

Kevin Tyan

  • Dana-Farber Cancer Institute
  • Harvard University

External person

Henning Willers

  • Harvard University

External person

Joshua Labaer

  • Arizona State University
  • Harvard University
  • Virginia G. Piper Center for Personalize Diagnostics
  • Department of Biological Chemistry and Molecular Pharmacology

External person

Lauren Gunasti

  • Harvard University

External person

Lisa Mahnke

  • EMD Serono

External person

Alicia Smart

  • Massachusetts Institute of Technology
  • Dana-Farber Cancer Institute

External person

Jonathan W. Goldman

  • University of California at Los Angeles
  • University of California Office of the President

External person

John Fasciano

  • Morgan Stanley Smith Barney
  • Dana-Farber Cancer Institute

External person

Sarah E. Shelton

  • Massachusetts Institute of Technology
  • Dana-Farber Cancer Institute

External person

Zhi Wei

  • New Jersey Institute of Technology
  • Department of Computer Science

External person

Shunsuke Kitajima

  • Dana-Farber Cancer Institute

External person

Joshua Wong

  • Dana-Farber Cancer Institute

External person

Zuliang Yuan

  • Harvard University

External person

Christine H. Chung

  • Vanderbilt University
  • Divison of Hematology/Oncology
  • University of South Florida
  • Johns Hopkins University

External person

William J. Stott

  • Oregon Health and Science University

External person

Lance Stapleton

  • Gilead Sciences, Inc.

External person

Hina J. Shah

  • Harvard University

External person

Claire Manuszak

  • Dana-Farber Cancer Institute

External person

Zhiheng Jia

  • Gilead Sciences, Inc.

External person

William J. Gibson

  • Dana-Farber Cancer Institute
  • Department of Cancer Biology
  • Harvard University
  • Broad Institute
  • Harvard-MIT Division of Health Sciences and Technology

External person

E. Y. Zhu

  • Loxo Oncology

External person

John C. Morris

  • Mayo Clinic Rochester, MN
  • Department of Endocrinology

External person

Prafulla C. Gokhale

  • Dana-Farber Cancer Institute

External person

Zhihong Wang

  • Harvard University
  • China Medical University

External person

Jonathan Z. Li

  • Harvard University
  • Infectious Disease Division

External person

Deborah A. Dillon

  • Harvard University
  • Yale University
  • Department of Pathology
  • Department of Pathology
  • Department of Pathology
  • Dana-Farber Cancer Institute
  • Department of Pathology
  • Department of Pathology

External person

Jeffrey K. Mito

  • Harvard University

External person

Timothy J. Henrich

  • Harvard University
  • Division of Experimental Medicine

External person

Chaoran Cheng

  • New Jersey Institute of Technology

External person

Mizuki Nishino

  • Dana-Farber Cancer Institute

External person

Marshall R. Posner

  • Harvard University
  • Icahn School of Medicine at Mount Sinai

External person

Chrysalyne D. Schmults

  • Harvard University
  • Dana-Farber
  • Mohs Micrographic Surgery Unit
  • Brigham and Women's Cancer Center
  • Dana-Farber/Brigham and Women's Cancer Center
  • Cutaneous Oncology

External person

Krystof Misiwkeiwicz

  • Icahn School of Medicine at Mount Sinai

External person

H. Delagrèverie

  • Harvard University
  • Université Paris Cité

External person

C. Thanh

  • Division of Experimental Medicine

External person

David Dornan

  • Gilead Sciences, Inc.

External person

Sara Ahmadi

  • Harvard University

External person

Meenhard Herlyn

  • Wistar Institute
  • Dana-Farber Cancer Institute
  • Center for Systems and Computational Biology
  • Melanoma Research Center

External person

Yingshi Guo

  • Ohio State University

External person

Huu Tuan Nguyen

  • Massachusetts Institute of Technology

External person

Lindsay E. Kuo

  • Temple University

External person

Kathleen B. Yates

  • Dana-Farber Cancer Institute
  • Harvard University
  • Department of Pediatric Oncology
  • Department of Pediatric Oncology

External person

Paul Kirschmeier

  • Duke University
  • Dana-Farber Cancer Institute

External person

Benchun Miao

  • Harvard University

External person

D. S.W. Tan

  • National Cancer Centre

External person

Tran C. Thai

  • Dana-Farber Cancer Institute

External person

Sigitas Verselis

  • Dana-Farber Cancer Institute

External person

Georgios Pavlou

  • Massachusetts Institute of Technology

External person

Marie F. Kijewski

  • Harvard University

External person

J. C R Jones

  • Northwestern University
  • National Institutes of Health
  • NW University Medical School
  • NW University Medical School
  • Washington State University Pullman
  • Department of Cell and Molecular Biology
  • Department of Cell and Molecular Biology
  • Robert H. Lurie Compreh. Cancer Ctr.
  • Dept. of Cell and Molec. Biology
  • Department of Cell and Molecular Biology
  • Department of Cell Biology and Anatomy
  • Dept. of Cell and Molecular Biology
  • Division of Allergy-Immunology
  • Department of Cell and Molecular Biology
  • Department of Cell
  • Cell Death Regulation Laboratory
  • Division of Pulmonary and Critical Care Medicine
  • the Division of Pulmonary Medicine
  • Dept. Of Cell and Molecular Biology
  • Dept. of Cell and Molecular Biology
  • Dept. of Cell and Molecular Biology
  • Departments of Infectious Diseases and Cell and Molecular Biology
  • Department of Medicine
  • Department of Cell and Molecular Biology
  • the Department of Molecular Biology
  • Department of Cell and Molecular Biology
  • Medical School
  • Department of Dermatology
  • Dept. of Cell and Molecular Biology
  • Cell and Molecular Biology
  • Dept. of Cell and Molecular Biology
  • School of Molecular Biosciences
  • Dermatology and Pediatrics
  • Robert H. Lurie Comprehensive Cancer Center
  • Department of Cell and Molecular Biology
  • Departments of Cell and Molecular Biology
  • Department of Cell and Molecular Biology
  • Department of Cell and Molecular Biology
  • Department of Molecular Biology
  • Department of Cell and Molecular Biology
  • Department of Cell and Molecular Biology
  • Department of Cell and Molecular Biology

External person

Anat O. Stemmer-Rachamimov

  • Harvard University
  • Department of Pathology
  • Department of Pathology

External person

Kai W. Wucherpfennig

  • Harvard University

External person

Jasmin Lebastchi

  • Harvard University

External person

Raymond H. Mak

  • Dana-Farber Cancer Institute

External person

Nehal Lakhani

  • Cancer and Hematology Centers of Western Michigan
  • START Midwest

External person

Alvaro C. Laga

  • Harvard University
  • Department of Pathology

External person

Travis Zack

  • Dana-Farber Cancer Institute
  • University of Texas MD Anderson Cancer Center
  • National Institutes of Health
  • Broad Institute
  • Massachusetts Institute of Technology
  • Harvard University
  • Department of Genomic Medicine
  • Department of Medical Oncology
  • Cancer Genome Atlas Program Office
  • Program in Biophysics
  • Department of Cancer Biology
  • Harvard-MIT Division of Health Sciences and Technology

External person

Hans J. Grote

  • Merck KGaA

External person

Supurna Ghosh

  • The University of Chicago
  • Northwestern University
  • NW University Medical School
  • Pulmonary and Critical Care Section
  • Department of Cell and Molecular Biology
  • Department of Cell and Molecular Biology
  • Department of Molecular Biology
  • Department of Medicine
  • Prentice Women’s Hospital

External person

M. H. Taylor

  • Oregon Health and Science University

External person

Norman E. Sharpless

  • University of North Carolina at Chapel Hill
  • National Institutes of Health
  • Cancer Genome Atlas Program Office

External person

Yanan Guo

  • Harvard University

External person

J. Longtine

  • Harvard University

External person

Jonathan J. Beitler

  • Emory University

External person

Yuehan Zhang

  • Johns Hopkins University

External person

J. M. Cuillerot

  • Medical Oncology, Inc.
  • EMD Serono

External person

M. Kroiss

  • University of Würzburg

External person

M. E. Burkard

  • University of Wisconsin-Madison

External person

K. Ebata

  • Loxo Oncology

External person

Alyssa F. Bacay

  • Dana-Farber Cancer Institute

External person

Osama E. Rahma

  • Harvard University

External person

Maria Fonfria

  • Harvard University

External person

Janessa Laskin

  • University of British Columbia
  • BC Cancer

External person

Leonard I. Zon

  • Harvard University

External person

Atul Gawande

  • Harvard University
  • Ariadne Labs
  • Community Empowerment Lab
  • University of Maryland, Baltimore
  • Department of Surgery
  • Department of Health Policy and Management
  • Center for Surgery and Public Health
  • Harvard T.H. Chan School of Public Health
  • Department of Health Policy and Management
  • School of Nursing

External person

Haixia Guan

  • Harvard University
  • China Medical University

External person

Steven G. Deeks

  • University of California at San Francisco

External person

Eric Haines

  • Dana-Farber Cancer Institute

External person

Hailun Li

  • Dana-Farber Cancer Institute
  • Harvard University
  • ECOG-ACRIN
  • Dana-Farber/Harvard Cancer Center

External person

Jason L. Weirather

  • Harvard University

External person

Bixiao Zhao

  • Harvard University

External person

Carolyn Hsu

  • Harvard University

External person

Bart Phillips

  • Gilead Sciences, Inc.

External person

Frank Kuo

  • Harvard University
  • Department of Pathology

External person

S. Leboulleux

  • ComUE Paris-Saclay
  • Institut Gustave Roussy

External person

Alessandra L. Moore

  • Harvard University

External person

H. Hartig

  • University of California at San Francisco

External person

Sana Iqbal

  • University of Maryland, Baltimore

External person

Patrick J. Roberts

  • G1 Therapeutics, Inc.
  • University of North Carolina at Chapel Hill

External person

Naifa Lamki Busaidy

  • University of Texas at Austin
  • University of Texas MD Anderson Cancer Center
  • Department of Endocrine Neoplasia and Hormonal Disorders

External person

Hans Vitzthum

  • Harvard University

External person

Rohit Thummalapalli

  • Harvard University
  • Broad Institute
  • Department of Pathology
  • Epigenomics Program
  • Dana-Farber Cancer Institute

External person

Marc R. Hammond

  • Harvard University

External person

James M. Cleary

  • Dana-Farber Cancer Institute
  • Early Drug Development Center

External person

Adriano Piris

  • Harvard University

External person

M. Sharon Stack

  • Northwestern University
  • University of Missouri
  • The University of Chicago
  • University of Notre Dame
  • NW University Medical School
  • NW University Medical School
  • Department of Pathology and Anatomical Sciences
  • Department of Cell and Molecular Biology
  • Dept. of Pathology and Anatomical Sciences
  • Departments of Cell and Molecular Biology
  • Robert H. Lurie Comprehensive Cancer Center
  • Dept. of Chemistry and Biochemistry
  • Department of Obstetrics and Gynecology
  • Dept. Of Cell and Molecular Biology
  • Division of Gynecologic Oncology
  • John I. Brewer Trophoblastic Disease Center
  • Robert H. Lurie Compreh. Cancer Ctr.
  • Department of Cell and Molecular Biology
  • Department of Medical Pharmacology and Physiology
  • Dept. of Obstetrics and Gynecology
  • Department of Medicine
  • Department of Cell and Molecular Biology
  • Dept. of Obstetrics and Gynecology
  • Departments of Gynecology
  • Department of Molecular Biology
  • Departments of Infectious Diseases and Cell and Molecular Biology
  • Department of Medical Pharmacology and Physiology
  • Robert H. Lurie Comprehensive Cancer Center of Northwestern University
  • Department of Obstetrics and Gynecology
  • Department of Cell and Molecular Biology

External person

Nathalie Silva De Morais

  • Universidade Federal do Rio de Janeiro
  • Harvard University
  • Instituto Estadual de Diabetes e Endocrinologia Luiz Capriglione

External person

William Walker

  • Dana-Farber Cancer Institute

External person

Tushara Vijaykumar

  • Dana-Farber Cancer Institute

External person

Ali Amin-Mansour

  • Massachusetts Institute of Technology

External person

Viola W. Zhu

  • University of California at Irvine

External person

Maura L. Gillison

  • Ohio State University
  • Case Western Reserve University
  • James Cancer Hospital
  • James Cancer Hospital and Solove Research Institute
  • Viral Oncology
  • University of Texas MD Anderson Cancer Center
  • Johns Hopkins University
  • Northwestern University
  • University of Texas MD AndersonCancer Center

External person

Oliver Gautschi

  • Department of Medical Oncology
  • Department of Cardiology
  • Department of Medical Oncology
  • University of Bern
  • Research Laboratories
  • Kantonsspital Luzern

External person

Hannah L. Johnson

  • Harvard University

External person

Lynette M. Sholl

  • Harvard University
  • Mayo Clinic Rochester, MN
  • Northwestern University
  • Department of Dermatology
  • Department of Pathology
  • Department of Dermatology
  • Department of Laboratory Medicine and Pathology

External person

Elizabeth Y. Wu

  • Harvard University

External person

Mara Rosenberg

  • Broad Institute
  • National Institutes of Health
  • Cancer Genome Atlas Program Office
  • Harvard University
  • Massachusetts Institute of Technology

External person

Kathleen Settle

  • University of Maryland, Baltimore

External person

David B. Donner

  • University of California at San Francisco
  • Indiana University-Purdue University Indianapolis
  • Indiana University Bloomington

External person

Heather Daley

  • Harvard University

External person

Raven Vlahos

  • Dana-Farber Cancer Institute

External person

Meng Xiao He

  • Massachusetts Institute of Technology
  • Dana-Farber Cancer Institute

External person

Lauren E. Bufe

  • Dana-Farber Cancer Institute

External person

C. De La Fouchardière

  • Centre Léon Bérard

External person

Anne O’Neill

  • Dana-Farber Cancer Institute

External person

Raymond Y. Huang

  • Harvard University
  • Center for Neurological Imaging

External person

Mark A. Varvares

  • Division of Thyroid and Parathyroid Endocrine Surgery
  • Harvard University

External person

Stephanie L. Lee

  • Boston University

External person

Kevin Chin

  • EMD Serono

External person

J. E. Bisi

  • Pennsylvania State University
  • GlaxoSmithKline
  • Division of Biology
  • G1 Therapeutics, Inc.

External person

Changwan Lu

  • University of Maryland, Baltimore

External person

Peter M. Wayne

  • Harvard University

External person

Gerald P. Linette

  • Washington University St. Louis
  • University of Pennsylvania
  • Hematology-Oncology
  • Center for Cellular Immunotherapies

External person

Julie E. Buring

  • Harvard University
  • Division of Preventive Medicine
  • Department of Medicine
  • Department of Epidemiology
  • Department of Epidemiology
  • Department of Medicine
  • Division of Preventive Medicine
  • Department of Medicine
  • USPHS
  • WHS

External person

Fadlo R. Khuri

  • University of Texas MD Anderson Cancer Center
  • Emory University
  • National Institutes of Health
  • Cancer Genome Atlas Program Office
  • Department of Hematology and Medical Oncology
  • Department of Leukemia
  • Winship Cancer Institute
  • Department of Hematology/Oncology
  • American University of Beirut

External person

Jeremiah Wala

  • Dana-Farber Cancer Institute
  • Department of Cancer Biology
  • Harvard University
  • Broad Institute
  • Bioinformatics and Integrative Genomics
  • University of California at San Francisco
  • Harvard-MIT Division of Health Sciences and Technology

External person

Marcia S. Brose

  • University of Pennsylvania
  • Division of Pulmonary, Allergy and Critical Care
  • Departments of Medicine
  • Departments of Otorhinolaryngology

External person

Ana Lako

  • Harvard University
  • Bristol-Myers Squibb

External person

Jennifer E. Gerber

  • Johns Hopkins University

External person

Paul B. Shyn

  • Harvard University

External person

Brooke E. Howitt

  • Stanford University

External person

Peter C. Everett

  • Boston University

External person

Harvey J. Mamon

  • Dana-Farber Cancer Institute

External person

Lisa Cameron

  • Dana-Farber Cancer Institute

External person

Benjamin Izar

  • Broad Institute
  • Dana-Farber Cancer Institute
  • Department of Medical Oncology
  • Harvard University
  • Department of Medical Oncology and Center for Cancer Precision Medicine
  • Massachusetts Institute of Technology

External person

H. Jacene

  • Dana-Farber Cancer Institute
  • Department of Imaging
  • Harvard University

External person

David S. Rosenthal

  • Leonard P. Zakim Center for Integrative Therapies

External person

C. R. Simoneau

  • Harvard University
  • University of California at San Francisco

External person

Weidong Lu

  • Leonard P. Zakim Center for Integrative Therapies

External person

M. Nguyen

  • Loxo Oncology

External person

Yu Hui Chen

  • Dana-Farber Cancer Institute

External person

Andrew G. Sikora

  • Dan L. Duncan Cancer Center
  • Baylor College of Medicine
  • Department of Otolaryngology - Head and Neck Surgery

External person

Yin Wu

  • University of Maryland, Baltimore

External person

Michael S. Gordon

  • Harvard University

External person

Encarnacion Reche

  • Medical Oncology

External person

R. L. Rutishauser

  • Division of Experimental Medicine

External person

Karl T. Kelsey

  • Brown University
  • Departments of Epidemiology

External person

Grit S. Herter-Sprie

  • Dana-Farber Cancer Institute

External person

J. I. Clark

  • Loyola University Chicago
  • Department of Veterans Affairs
  • Cardinal Bernardin Cancer Center

External person

Shirani D. Rajan

  • Louisiana State University

External person

Stephanie A. Lynch

  • Harvard University

External person

Sarah N. Zaheer

  • Harvard University

External person

Erin Carroll

  • Dana-Farber Cancer Institute

External person

Daniel R. Clayburgh

  • The University of Chicago
  • Department of Pathology
  • Department of Pathology
  • Oregon Health and Science University

External person

Stephanie K. La Follette

  • Harvard University

External person

Brian C. Miller

  • Dana-Farber Cancer Institute

External person

Fiona M. Fennessy

  • Harvard University

External person

Zhengpeng Wan

  • Massachusetts Institute of Technology
  • Dana-Farber Cancer Institute

External person

W. Nicholas Haining

  • Harvard University
  • McMaster University
  • Broad Institute
  • Department of Pediatric Oncology
  • Dana-Farber Cancer Institute
  • Division of Hematology/Oncology
  • Department of Pediatric Oncology

External person

Yanxi Zhang

  • Dana-Farber Cancer Institute

External person

Laura A. Linz-McGillem

  • NW University Medical School
  • Northwestern University
  • Department of Molecular Biology

External person

J. Kherani

  • Loxo Oncology

External person

Mei Ju Su

  • Dana-Farber Cancer Institute

External person

Daniel E. Sammartino

  • Dana-Farber Cancer Institute

External person

Andrew Portell

  • Dana-Farber Cancer Institute

External person

Francisco M. Marty

  • Harvard University
  • Infectious Disease Division
  • Dana-Farber Cancer Institute
  • Division of Hematologic Malignancies

External person

X. Huang

  • Loxo Oncology

External person

C. C. Wang

  • University of California at San Francisco

External person

Tim Waterboer

  • Infections and Cancer Epidemiology
  • German Cancer Research Center

External person

Joshua A. Kaplan

  • Gilead Sciences, Inc.

External person

Susanna Stinson

  • Gilead Sciences, Inc.

External person

Haribabu Arthanari

  • Harvard University

External person

Brendan Ross

  • McGill University
  • Harvard University

External person

Juan Miret

  • Dana-Farber Cancer Institute

External person

Hailey Becker

  • Harvard University

External person

Jay C. Strum

  • G1 Therapeutics, Inc.

External person

Jean M. Connors

  • Harvard University

External person

David Kwiatkowski

  • University College London
  • Harvard University
  • Harvard Ptnrs. Ctr. Genet. Genom.
  • Dana-Farber Cancer Institute
  • National Institutes of Health
  • Harvard Ptnrs. Ctr. Genet. Genom.
  • Department of Medical Oncology
  • Department of Medicine
  • Department of Medical Oncology
  • Department of Medicine
  • Hematology Division
  • Cancer Genome Atlas Program Office
  • Division of Hematology
  • Hematology Division
  • Channing Laboratory
  • Department of Medicine
  • Massachusetts Institute of Technology

External person

Brendan D. Price

  • Harvard University

External person

Jeffrey Kaufman

  • Adenoid Cystic Carcinoma Research Foundation

External person

Asha Sarma

  • Harvard University

External person

Ting Chen

  • Dana-Farber Cancer Institute

External person

Michal Barzily-Rokni

  • Harvard University

External person

Sarah Riley

  • Dana-Farber Cancer Institute

External person

Jason L. Hornick

  • Harvard University
  • Department of Pathology
  • Cancer Genome Atlas Program Office
  • National Institutes of Health
  • Department of Pathology
  • University of Washington

External person

S. M. Rothenberg

  • Loxo Oncology

External person

Scott J. Swanson

  • Johns Hopkins University
  • Harvard University
  • Dana-Farber/Brigham and Women's Cancer Center
  • Division of Thoracic Surgery
  • Div. Thorac. Surg. Pulmon./C.
  • Department of Thoracic Surgery
  • Joint Center for Radiation Therapy
  • Thoracic Surgery
  • Division of Thoracic Surgery
  • NETT Coordinating Center
  • Thoracic Oncology Program
  • Divisions of Plastic and Thoracic Surgery
  • Departments of Surgery

External person

Earl V. Cambell

  • University of Maryland, Baltimore

External person

S. Bakkour

  • Blood Systems Research Institute

External person

Stephen T. Sonis

  • Harvard University
  • Biomodels, LLC
  • Department of Surgery
  • Division of Oral Medicine

External person

Weihong Xiao

  • Ohio State University

External person

Douglas R. Adkins

  • Washington University St. Louis
  • Case Western Reserve University
  • Department of Medicine
  • University of Washington
  • Siteman Cancer Center
  • Johns Hopkins University
  • Northwestern University

External person

Shital S. Patel

  • University of Maryland, Baltimore

External person

Hanna C. Pawluk

  • British Columbia Cancer Agency Research Centre British

External person

Scott Strome

  • Mayo Clinic Rochester, MN
  • Department of Otorhinolaryngology
  • University of Maryland, Baltimore

External person

T. Owonikoko

  • Emory University
  • Department of Oncology
  • Cancer Genome Atlas Program Office
  • National Institutes of Health
  • Department of Hematology and Medical Oncology

External person

John R. Murphy

  • Boston University

External person

Michael Short

  • British Columbia Cancer Agency Research Centre British

External person

Ruben Dries

  • Dana-Farber Cancer Institute

External person

J. Medioni

  • Hôpital européen Georges Pompidou

External person

Todd M. Bauer

  • Sarah Cannon Research Institute

External person

Jonathan A. Nowak

  • Harvard University

External person

Nikhil Wagle

  • Dana-Farber Cancer Institute
  • Harvard University
  • Broad Institute
  • Department of Medicine
  • Department of Medical Oncology
  • Massachusetts Institute of Technology

External person

Mark F. Coughlin

  • Massachusetts Institute of Technology

External person

Charles H. Yoon

  • Harvard University

External person

Maria Puzanov

  • Harvard University

External person

Tian Tian

  • New Jersey Institute of Technology

External person

Vivek Subbiah

  • University of Texas MD Anderson Cancer Center
  • Department of Investigational Cancer Therapeutics
  • Phase IProgram
  • University of Texas Health Science Center at Houston

External person

David M. Sabatini

  • Massachusetts Institute of Technology
  • Harvard University
  • Whitehead Institute for Biomedical Research
  • Howard Hughes Medical Institute
  • Department of Biology
  • Broad Institute

External person

Galit Alter

  • Massachusetts Institute of Technology
  • Harvard University
  • Ragon Institute of MGH
  • Massachusetts Consortium on Pathogen Readiness

External person

Sara Abdelrahman

  • Dana-Farber Cancer Institute
  • Harvard University

External person

Levi Garraway

  • Dana-Farber Cancer Institute

External person

Fei Dong

  • Harvard University

External person

Frank Worden

  • Case Western Reserve University
  • Rogel Cancer Center
  • University of Michigan
  • University of Michigan, Ann Arbor
  • Rogel Cancer Center
  • Johns Hopkins University
  • Northwestern University

External person

Asaf Rotem

  • Harvard University
  • Dept. Biol. Chem. Molec. Pharmacol.
  • Dana-Farber Cancer Institute
  • Broad Institute
  • Department of Medical Oncology and Center for Cancer Precision Medicine

External person

Peng Gao

  • Dana-Farber Cancer Institute

External person

Jens Lohr

  • Broad Institute
  • Dana-Farber Cancer Institute

External person

Milhan Telatar

  • City of Hope National Med Center

External person

Aditya V. Shreenivas

  • Harvard University

External person

Stuart G. Silverman

  • Harvard University
  • Department of Radiology
  • Department of Radiology

External person

Nikolaos Nikitakis

  • University of Maryland, Baltimore

External person

Haishan Zeng

  • British Columbia Cancer Agency Research Centre British

External person

Annie W. Lavigne

  • Harvard University

External person

F. Barlesi

  • Aix-Marseille Université

External person

Lauren Keogh

  • Dana-Farber Cancer Institute

External person

Zoe Ciantra

  • Harvard University

External person

Sandeep Chhabra

  • Harvard University

External person

Eric A. Macklin

  • Harvard University

External person

Michael Busch

  • Blood Systems Research Institute

External person

James A. DeCaprio

  • Dana-Farber Cancer Institute

External person

V. Moreno

  • Universidad Autónoma de Madrid

External person

Adrienne Luoma

  • Harvard University

External person

Ju Mei Ng

  • Harvard University

External person

Jinyan Du

  • Massachusetts Institute of Technology

External person

Jean Pierre Eliane

  • Harvard University

External person

Manisha H. Shah

  • Ohio State University
  • Medical Oncology
  • Medical Oncology
  • James Cancer Hospital
  • Arthur G. James Cancer Hospital
  • Department of Internal Medicine

External person

Theodora Pappa

  • Dana-Farber Cancer Institute
  • Harvard University

External person

A. B. Riemer

  • Dana-Farber Cancer Institute

External person

Anusha R. Tanguturi

  • Boston University

External person

Y. Godbert

  • Université de Bordeaux

External person

Shun Zhang

  • Massachusetts Institute of Technology

External person

Kevin Guze

  • Harvard University

External person

John R. Clark

  • Harvard University

External person

Kee Young Shin

  • Dana-Farber Cancer Institute

External person

Frank He

  • Massachusetts Institute of Technology

External person

J. Weiss

  • University of North Carolina at Chapel Hill

External person

Andrew Bang

  • Dana-Farber Cancer Institute

External person

Charles T. Quinn

  • Dana-Farber Cancer Institute

External person

Brian C. Grabiner

  • Massachusetts Institute of Technology
  • Whitehead Institute for Biomedical Research

External person

Bruce Robinson

  • Royal North Shore Hospital

External person

Nicole Spardy Burr

  • Adenoid Cystic Carcinoma Research Foundation

External person

Rifaquat M. Rahman

  • Harvard University
  • Dana-Farber Cancer Institute

External person

L. Yang

  • Loxo Oncology

External person

Hyung Jin Yoo

  • Harvard University

External person

E. Sherman

  • Memorial Sloan-Kettering Cancer Center

External person

Eileen P. Scully

  • Johns Hopkins University
  • Harvard University

External person

Alexander Frieden

  • Harvard University

External person

Vivek Sivathanu

  • Massachusetts Institute of Technology

External person

Chandrasekar Venkataramani

  • Gilead Sciences, Inc.

External person

Caroline A. Alexander

  • Harvard University

External person

Edmund S. Cibas

  • Harvard University
  • Department of Pathology

External person

Shamik Bhattacharyya

  • Harvard University

External person

Julian Huang

  • Harvard University

External person

Ann Marie Egloff

  • University of Pittsburgh
  • Department of Otolaryngology
  • Department of Otolaryngology
  • Harvard University

External person

Jessica Stuart

  • Harvard University

External person

Gao Zhang

  • Wistar Institute

External person

H. Kang

  • University of California at San Francisco

External person

Vivek Kumar

  • Harvard University

External person

Gad Getz

  • Broad Institute
  • Cancer Genome Atlas Program Office
  • National Institutes of Health
  • Harvard University
  • Cancer Center and Department of Pathology
  • Department of Pathology
  • Department of Biology and Biochemistry
  • Dana-Farber Cancer Institute
  • University of Houston
  • Department of Medical Oncology
  • Genetic Analysis Platform
  • Massachusetts Institute of Technology
  • Department of Physics of Complex Systems
  • Weizmann Institute of Science
  • Cancer Program
  • Stanford University
  • Department of Genetics
  • Department of Pathology
  • Department of Pathology
  • Center for Cancer Research

External person

H. J. Schmoll

  • Martin Luther University Halle-Wittenberg
  • Department for Internal Medicine IV
  • Department of Internal Medicine IV
  • Monash University
  • Department of Epidemiology and Preventive Medicine

External person

Parin Shah

  • Dana-Farber Cancer Institute
  • University of Texas MD Anderson Cancer Center

External person

B. Levy

  • Johns Hopkins University

External person

M. McClean

  • Boston University

External person

Helmut G. Rennke

  • Harvard University
  • Department of Medicine
  • Department of Pathology
  • Department of Pathology

External person

Mohan Suntharalingam

  • University of Maryland, Baltimore

External person

Atul B. Shinagare

  • Harvard University

External person

Sandeep Ghai

  • Boston University

External person

Ludmila M. Flores

  • Harvard University

External person

Sara E. Higgins

  • Harvard University

External person

Jessica A. Sorrentino

  • G1 Therapeutics, Inc.

External person

Mai Anh Huynh

  • Harvard University

External person

Xiaofeng Jiang

  • Harvard University

External person

Alexander Drilon

  • Memorial Sloan-Kettering Cancer Center
  • Gynecologic Medical Oncology Service
  • Cornell University

External person

Ratna Sen

  • Northwestern University
  • NW University Medical School
  • Robert H. Lurie Comprehensive Cancer Center
  • Department of Cell and Molecular Biology
  • Department of Molecular Biology
  • Robert H. Lurie Comprehensive Cancer Center of Northwestern University
  • Robert H. Lurie Compreh. Cancer Ctr.

External person